Flinders at Tonsley is home to the national headquarters of the Medical Device Partnering Program, an ideas incubator fostering collaborations between researchers, industry and end-users to develop medical technologies with global market potential.
The MDPP is able to leverage a diverse range of expertise to contribute to product conceptualisation, and with a dedicated laboratory on-site, the MDPP can deliver a confidential, focused 250-hour project, combined with a product opportunity assessment, for clients.
The MDPP provides a mechanism to develop proof-of-concept, prototyping, clinical evaluation and commercisation planning. Ideas that are brought to the MDPP cover a range of solutions including therapeutics devices, diagnostics, hospital equipment and accessories, surgical instruments, assistive technologies and software and simulation tools.
The MDPP also partners with industry growth centre, MTPConnect, to deliver a number of national funding programs including the Biomedical Translation Bridge (BTB), Targeted Translation Research Accelerator (TTRA) and Clinical Translation and Commercialisation - Medtech (CTCM) programs.